USPSTF Recommends Behavioral Interventions for Pediatric Weight Loss
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 12, 2023 -- The U.S. Preventive Services Task Force (USPSTF) recommends intensive behavioral interventions for children and teenagers with a high body mass index (BMI). This recommendation forms the basis of a draft recommendation statement published online Dec. 12.
Elizabeth O'Connor, Ph.D., from the Kaiser Permanente Evidence-based Practice Center in Portland, Oregon, and colleagues examined the benefits and harms of weight management interventions (behavioral, liraglutide, semaglutide, orlistat, and phentermine/topiramate) in health care settings for children and adolescents with high BMI. Data were included from 58 randomized controlled trials, with 10,143 participants. The researchers found that behavioral weight management interventions were associated with small decreases in BMI and other weight-related outcomes after six to 12 months; in interventions with higher contact hours and that offered physical activity sessions, larger effects were seen. Trials offering 26 or more hours of intervention contact showed improvements in blood pressure and fasting plasma glucose after six to 12 months. The largest effects on BMI were seen for semaglutide and phentermine/topiramate; smaller effects on BMI were seen after 12 to 13 months for liraglutide and orlistat.
Based on these findings, the USPSTF recommends that clinicians provide or refer children aged 6 years or older with high BMI to comprehensive, intensive behavioral interventions (grade B recommendation). Children and adolescents with a high BMI should receive intensive behavioral interventions to achieve benefit.
The draft evidence review and draft recommendation statement have been posted for public comment. Comments can be submitted from Dec. 12, 2023, through Jan. 16, 2024.
Draft Recommendation Statement
Comment on Recommendation Statement
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...
Weight Navigation Program Boosts Use of Weight Management Treatments
FRIDAY, May 31, 2024 -- A primary care-based weight navigation program (WNP) is feasible and associated with greater use of weight management treatments (WMT) and weight loss...
Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation
WEDNESDAY, May 29, 2024 -- Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.